{"data":{"id":450,"citation":"Hegedus C, Ozvegy-Laczka C, Ap\u00e1ti A, Mag\u00f3csi M, N\u00e9met K, Orfi L, K\u00e9ri G, Katona M, Tak\u00e1ts Z, V\u00e1radi A, Szak\u00e1cs G, Sarkadi B.: Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties. Br J Pharmacol, Volume 158 (4), 2009","title":"Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties.","doi":"10.1111\/j.1476-5381.2009.00383.x","doi_url":"https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00383.x","pmid":"19785662","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/19785662\/","year":2009,"journal":"Br J Pharmacol","volume":"158","issue":"4","page":"1153-1164","authors":[{"first_name":"Ap\u00e1ti A","last_name":null,"full_name":null},{"first_name":"Hegedus C","last_name":null,"full_name":null},{"first_name":"Katona M","last_name":null,"full_name":null},{"first_name":"K\u00e9ri G","last_name":null,"full_name":null},{"first_name":"Mag\u00f3csi M","last_name":null,"full_name":null},{"first_name":"N\u00e9met K","last_name":null,"full_name":null},{"first_name":"Orfi L","last_name":null,"full_name":null},{"first_name":"Ozvegy-Laczka C","last_name":null,"full_name":null},{"first_name":"Sarkadi B.","last_name":null,"full_name":null},{"first_name":"Szak\u00e1cs G","last_name":null,"full_name":null},{"first_name":"Tak\u00e1ts Z","last_name":null,"full_name":null},{"first_name":"V\u00e1radi A","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/450","landing_page":"https:\/\/molmedb.upol.cz\/publication\/450","created_at":"2020-07-09T15:14:36.000000Z","updated_at":null}}